Diabetes Canada End Diabetes 2023 Awards


Descriptions

Opportunity type:

Grant

Sponsor:

Diabetes Canada

Award amount and duration:

$100,000 annually for 3 years ($300,000 total)

Eligibility

Type:
Faculty

Eligibility: The Nominated Principal Applicant must be an independent researcher. The Nominated Principal Applicant and Co-Applicant(s) must have an academic or research
appointment with an eligible Canadian institution.

The Nominated Principal Applicant on an End Diabetes 2023 Award is not eligible to apply for or hold more than one research funding award from Diabetes Canada at any time as the principal applicant. Partnered grants awarded through another funder are not included in this limit.


If, at the time of applying, the applicant does not have an independent faculty position (due to a requirement by their institution that he/she must secure independent peer-reviewed
operating grant funding prior to the position being finalized), then a detailed letter from the department Chair or Dean providing details regarding the faculty position must be included in the application. Failure to provide this letter will result in the application being declined. Diabetes Canada reserves the right to request additional information to clarify the position offered.. Diabetes Canada reserves the right to request additional information to confirm
independence. See definitions for details.

Summary

Diabetes Canada is proud to be a leading supporter of diabetes research in Canada. The End
Diabetes Fund supports biomedical, clinical, health services, and population health research in
diabetes and diabetes related complications to develop solutions aimed at the prevention,
treatment, management, and finding a cure(s) for people living with diabetes.


For the 2023 research funding competition, Diabetes Canada will be awarding approximately 20
End Diabetes 2023 Awards. Each of the 20 awards commits a $100,000 operating grant
annually for three years ($300,000 total) to support excellent research projects that enhance
our understanding of diabetes and its prevention, treatment, management, and cure.

The objective of the End Diabetes 2023 Awards are:
1. To support researchers in the discovery of biomedical, clinical, health services, and/or
population health factors that lead to the onset and progression of all types of diabetes
and related complications.
2. To develop solutions aimed at the prevention, management, and finding a cure(s) for
diabetes and its complications.
3. To address challenges in diabetes health services, and design and implement solutions
that improve healthcare delivery, health policies, and access to care for all communities
and populations affected by diabetes.

Full program guidelines available here.

Overhead

Overhead is not an eligible expense on this grant


Deadlines

Application deadlines

RSO final internal review deadline

Date:
June 27, 2023 - 12:00 PM

Program application deadline

Date:
June 30, 2023 - 6:00 PM

Approvals

NOTE: Consult your Faculty Associate Dean (Research) (ADR) regarding Faculty-specific deadlines and submission processes.

Principal Investigators: Complete a Research Management System (RMS) record, including a copy of your complete application, and submit this for approvals in RMS.

Postdocs, students, and trainees: For fellowships and externally-sponsored research training awards or opportunities, you must complete the Research Funding Application Approval (RFAA) Trainee PDF form, and submit it, along with a complete copy of the application, to Research Services at rsotrainee@ucalgary.ca. Trainees should not use RMS at this time.

Approvals: The University of Calgary requires that all funding applications be approved prior to submission. Approval requires signatures via either RMS or the RFAA Trainee form, in the following order:

  • Principal Investigator
  • Department Head
  • Faculty ADR/Dean
  • Research Services (on behalf of the Vice-President Research)

Read the Meaning of Grant Signatures policy to understand what your approval means. Please see the agency guidelines for details about which signatures are required on your application, as it may differ from internal requirements.

Late submissions: Late submissions will only be accepted in cases of medical or family emergencies, or other exceptional circumstances. If you submit your RMS record to Research Services after the internal deadline has passed, you must secure additional approvals. Please read: Late Applications Process.


Additional Information

Submission Instructions:

  1. Complete Full Application on the ResearchNet Portal and download a preview to pdf format.
  2. To initiate internal approvals, complete the Pre-Award/Application record in RMS (https://research.ucalgary.ca/conduct-research/additional-resources/resea...), attach your completed Application in pdf format, and submit for approvals from your department head and/or faculty Associate Dean (Research). *Important: when submitting in RMS, please ensure that you allow time for academic approvals prior to the Research Services review deadline of 12:00pm on Tuesday, June 27, 2023
  3. Once these approvals are obtained, RMS will automatically forward the Application record to Research Services for institutional review and approval.
  4. Research Services will review, provide feedback (by email) if necessary, and will provide the institutional approval. RSO will provide the capping institutional signature if needed and will advise when ready.
  5. Full Applications should be submitted to the agency via the ResearchNet portal on June 30, 2023 by 6:00PM Mountain Time.

Contact Details


Keywords

Diabetes Canada
End Diabetes 2023 Awards
Health Research